Yasufumi Uchida

Pravastatin and cardiovascular risk in moderate chronic kidney disease.

Y. Ohashi, Haruo M D Nakamura, K. Mizuno, 2009, Atherosclerosis.

Effects of pravastatin and atorvastatin on HDL cholesterol and glucose metabolism in patients with dyslipidemia and glucose intolerance: the PRAT study.

J. Sasaki, S. Kono, Y. Ikeda, 2013, Journal of atherosclerosis and thrombosis.

Association Between Blood Pressure Lowering and Quality of Life by Treatment of Azilsartan.

J. Oyama, K. Node, N. Fujiwara, 2017, International heart journal.

Effects of sitagliptin beyond glycemic control: focus on quality of life

J. Oyama, K. Node, Teruo Inoue, 2013, Cardiovascular Diabetology.

Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized Controlled Trial.

Y. Ouchi, S. Yamashita, Y. Ohashi, 2019, Circulation.

Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus

J. Oyama, K. Node, A. Shiraki, 2018, Geriatrics & gerontology international.

Endoscopic injection sclerotherapy for esophageal varices prolonged survival of patients with hepatocellular carcinoma complicating liver cirrhosis.

K. Fujimoto, R. Iwakiri, H. Sakata, 2000, Gastrointestinal endoscopy.